| Cold tumors: a therapeutic challenge for immunotherapy P Bonaventura, T Shekarian, V Alcazer, J Valladeau-Guilemond, ... Frontiers in immunology 10, 168, 2019 | 924 | 2019 |
| Human endogenous retroviruses (HERVs): shaping the innate immune response in cancers V Alcazer, P Bonaventura, S Depil Cancers 12 (3), 610, 2020 | 54 | 2020 |
| Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy P Bonaventura, V Alcazer, V Mutez, L Tonon, J Martin, N Chuvin, E Michel, ... Science Advances 8 (4), eabj3671, 2022 | 45 | 2022 |
| Immune checkpoint inhibitors rechallenge efficacy in non–small-cell lung cancer patients E Gobbini, AC Toffart, M Pérol, JB Assié, M Duruisseaux, D Coupez, ... Clinical lung cancer 21 (5), e497-e510, 2020 | 41 | 2020 |
| Toward “off‐the‐shelf” allogeneic CAR T cells BT Aftab, B Sasu, J Krishnamurthy, E Gschweng, V Alcazer, S Depil Advances in Cell and Gene Therapy 3 (3), e86, 2020 | 32 | 2020 |
| Neoepitopes-based vaccines: challenges and perspectives V Alcazer, P Bonaventura, L Tonon, S Wittmann, C Caux, S Depil European Journal of Cancer 108, 55-60, 2019 | 26 | 2019 |
| Cold tumors: a therapeutic challenge for immunotherapy. Front Immunol. 2019; 10: 168 P Bonaventura, T Shekarian, V Alcazer, J Valladeau-Guilemond, ... Epub 2019/02/26. https://doi. org/10.3389/fimmu. 2019.00168 PMID: 30800125, 2019 | 23 | 2019 |
| CML patients show sperm alterations at diagnosis that are not improved with imatinib treatment FE Nicolini, V Alcazer, F Huguet, P Cony-Makhoul, M Heiblig, MP Fort, ... Leukemia research 48, 80-83, 2016 | 22 | 2016 |
| Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible? A Conrad, V Alcazer, F Valour, F Ader Expert review of vaccines 17 (4), 299-309, 2018 | 20 | 2018 |
| Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia R Trad, W Warda, V Alcazer, MN da Rocha, A Berceanu, C Nicod, ... Journal for Immunotherapy of Cancer 10 (7), 2022 | 19 | 2022 |
| Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on front-line imatinib FE Nicolini, V Alcazer, P Cony-Makhoul, M Heiblig, S Morisset, G Fossard, ... Experimental Hematology 64, 97-105. e4, 2018 | 14 | 2018 |
| Gene signature of circulating platelet‐bound neutrophils is associated with poor prognosis in cancer patients P Lecot, M Ardin, S Dussurgey, V Alcazer, L Moudombi, ... International Journal of Cancer 151 (1), 138-152, 2022 | 12 | 2022 |
| B-cell malignancies and COVID-19: a narrative review D Luque-Paz, P Sesques, F Wallet, E Bachy, F Ader, ... Clinical Microbiology and Infection 29 (3), 332-337, 2023 | 10 | 2023 |
| Class I/Class II HLA evolutionary divergence ratio is an independent marker associated with disease-free and overall survival after allogeneic hematopoietic stem cell … AM Daull, V Dubois, H Labussiere-Wallet, F Venet, F Barraco, ... Frontiers in Immunology 13, 841470, 2022 | 10 | 2022 |
| VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell … A Conrad, M Boccard, F Valour, V Alcazer, ATT Sanchez, C Chidiac, ... BMJ open 9 (2), e026093, 2019 | 10 | 2019 |
| HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy V Alcazer, P Bonaventura, L Tonon, E Michel, V Mutez, C Fabres, ... American Journal of Hematology 97 (9), 1200-1214, 2022 | 9 | 2022 |
| StatAid: An R package with a graphical user interface for data analysis V Alcazer Journal of Open Source Software 5 (54), 2630, 2020 | 9 | 2020 |
| Early‐onset severe infections in allogeneic hematopoietic stem cell transplantation recipients with graft failure V Alcazer, A Conrad, F Valour, E Bachy, G Salles, A Huynh, RP de Latour, ... American Journal of Hematology 94 (4), E109-E111, 2019 | 9 | 2019 |
| How to obtain a high quality ctDNA in lymphoma patients: preanalytical tips and tricks E Bourbon, V Alcazer, E Cheli, S Huet, P Sujobert Pharmaceuticals 14 (7), 617, 2021 | 7 | 2021 |
| Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learning E Cheli, S Chevalier, O Kosmider, M Eveillard, N Chapuis, A Plesa, ... Haematologica 107 (6), 1466, 2022 | 4 | 2022 |
